Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000094.xml
Z Gastroenterol 2003; 41(8): 729-732
DOI: 10.1055/s-2003-41209
DOI: 10.1055/s-2003-41209
Übersicht
© Karl Demeter Verlag im Georg Thieme Verlag Stuttgart · New York
Chirurgische und medikamentöse Therapie der gastroösophagealen Refluxkrankheit
Konsens einer Pro- und Contra-DiskussionSurgical and Medical Therapy for Gastroesofageal Reflux DiseaseConsensus of Pro/Con Clinical DebateA. H. Hölscher2 , A. L. Blum1Further Information
Publication History
Manuskript-Eingang: 21. Januar 2003
Annahme nach Revision: 3. April 2003
Publication Date:
11 August 2003 (online)
Einleitung
Der nachfolgende Text wurde im Rahmen einer Pro- und Contra-Diskussion anlässlich der 57. Tagung der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (Präsident: Prof. Dr. Sauerbruch; Bonn, 14.9.2002) entwickelt. Die Aussagen unter den neun Konsenspunkten sind mit den aus Sicht der Autoren vorliegenden Evidenzgraden und den dazu ausschlaggebenden Literaturstellen aufgeführt (Evidenzgrade I-IV, Erklärung siehe unten). Das Literaturverzeichnis ist bis zum Februar 2003 nachgeführt worden.
Es werden folgende Abkürzungen verwendet:
C: chirurgische Antirefluxtherapie, M: medikamentöse Antirefluxtherapie.
Literatur
- 1 Dent J, Brun J, Fendrick A M. et al. On behalf of the Genval Workshop Group. . An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut. 1999; 44 (Suppl 2) 1-16
- 2 Inadomi J M, Jamal R, Murata G H. et al . Step-down management of gastroesophageal reflux disease. Gastroenterology. 2001; 121 (5) 1095-1100
- 3 Edwards S J, Lind T, Lundell L. Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis. Aliment Phamacol Ther. 2001; 15 1729-1736
- 4 Thjodleifsson B, Rindi G, Fiocca R. et al . A randomized double blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years. Aliment Pharmacol Ther. 2003; 17 343-351
- 5 Van der Peet D L, Klinkenberg-Knol E C, Eijsbouts Q AJ. et al . Laparoscopic Nissen fundoplication for the treatment of gastroesophageal reflux disease (GERD); surgery after extensive conservative treatment. Surg Endosc. 1998; 1 1159-1161
- 6 Campos G M, Peters J H, DeMeester T R. et al . Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg. 1999; 3 (3) 292-300
- 7 Kahrilas P J. Management of GERD: Medical versus surgical. Seminars in Gastrointestinal Disease. 2001a; 12 3-15
- 8 Kahrilas P J. Surgical therapy for reflux disease. JAMA. 2001b; 2376-2378
- 9 Galmiche J P, Zerbib F. Antagonist. Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Gut. 2002; 51 472-474
- 10 Lundell L. Protagonist. Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Gut. 2002; 51 468-471
- 11 Parilla P, de Martinez Haro LF, Ortiz A. et al . Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg. 2003; 237 291-298
- 12 Peghini P G, Katz P O, Castell D O. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects. Gastroenterology. 1998; 115 (6) 1335-1339
- 13 Farrell T M, Richardson W S, Trus T L. et al . Response of atypical symptoms of gastro-oesophageal reflux to antireflux surgery. Br J Surg. 2001; 88 (12) 1649-1652
- 14 Amin M R, Postma G N, Johnson P. et al . Proton pump inhibitor resistance in the treatment of laryngopharygeal reflux. Otolaryngol Head Neck Surg. 2001; 125 374-378
- 15 Reilly J P. Safety profile of the proton-pump inhibitors. Am J Health Syst Pharm. 1999; 56 (23, Suppl 4) S11-17
- 16 Gerson L B, Hatton B N, Ryono R. et al . Clinical and fiscal impact of lansoprazole intolerance in veterans with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2000; 4 (4) 397-406
- 17 Cordes A, Vogt W, Maier K P. Pantozol-induzierte Hepatitis. Dtsch Med Wochenschr. 2003; 128 611-614
- 18 Hungin A P, Rubin G, O'Flanagan H. Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. Br J Gen Pract. 1999; 49 (443) 463-464
- 19 Dent J. Controversies in long-term management of reflux disease. Baillère’s Clinical Gastroenterology. 2000; 14 811-826
- 20 Romagnuolo J, Meier M A, Sadowski D C. Medical or surgical therapy for erosive reflux esophagitis: cost utility analysis using a Markov model. Ann Surg. 2002; 236 (2) 191-202
- 21 O’Boyle C J, Watson D I, DeBeaux A C. et al . Preoperative prediction of long-term outcome following laparoscopic fundoplication. ANZ J Surg. 2002; 2 471-475
- 22 Granderath F A, Kamolz T, Schweiger U M. et al . Outcome after laparoscopic antireflux surgery: fundoplication and re-fundoplication in the elderly. Chirurg. 2001; 72 (9) 1026-1031
- 23 Klinkenberg-Knol E C, Festen H P, Jansen J B. et al . Long term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med. 1994; 121 (3) 161-167
- 24 Klinkenberg-Knol E C, Nelis F, Dent J. et al . Long term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology. 2000; 118 (4) 661-669
- 25 Peters F T, Ganesh S, Kuipers E J. et al . Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study. Gut. 1999; 45 489-494
- 26 Vela M F, Camacho Lobato L, Srinivasan R. et al . Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology. 2001; 120 (7) 1599-1606
- 27 Lundell L, Miettinen P, Myrvold H E. et al . Continued (5 year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coll Surg. 2001; 192 172-181
- 28 Taha A S, Angerson W J, Morran C G. Reflux and Barrett’s oesophagitis after gastric surgery - long-term follow-up and implications for the roles of gastric acid and bile in oesophagitis. Aliment Pharmacol Ther. 2003; 17 547-552
- 29 Ortiz A, de Martinez H aro LF, Parrilla P. et al . Conservative treatment versus antireflux surgery in Barrett’s oesophagus: long term results of a prospective study. Br J Surg. 1996; 83 (2) 274-278
- 30 Spechler S J, Lee E, Ahnen D. et al . Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA. 2001; 285 2331-2338
- 31 Ye W, Chow W H, Lagergren J. et al . Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology. 2001; 121 (6) 1286-1293
- 32 Klaus A, Hinder R A. Medical therapy versus antireflux surgery in Barrett’s esophagus: what is the best therapeutic approach?. Dig Dis. 2000-2001; 18 224-231
- 33 Gutschow C A, Schröder W, Prenzel K. et al . Impact of antireflux surgery on Barrett’s esophagus. Langenbecks Arch Surg. 2002; 387 3 - 4; 138 - 145
- 34 P van, Numans M E, Bonis P A. et al . Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev. 2001; 4 CD002095
- 35 Basu K K, Bale R, West K P. et al . Persistent acid reflux and symptoms in patients with Barrett’s oesophagus on proton-pump inhibitor therapy. Eur J Gastroenterol Hepatol. 2002; 14 (11) 1187-1192
- 36 You J H, Lee A C, Wong S C. et al . Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis. Aliment Pharmacol Ther. 2003; 17 785-792
- 37 Leeder P C, Watson D I, Jamieson G G. Laparoscopic fundoplication for patients with symptoms but no objective evidence of gastroesophageal reflux. Dis Esoph. 2002; 15 (4) 309-314
- 38 Maziak D E, Todd T RJ, Pearson F G. Massive hiatus hernia: evaluation and surgical management. J Thorac Cardiovasc Surg. 1998; 115 53-62
- 39 van Herwaarden M A, Samsom M, Smout A J. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations. Gastroenterology. 2000; 119 (6) 1439-1446
- 40 Jones M P, Sloan S S, Rabine J C. et al . Hiatal hernia size is the dominant determinant of esophagitis presence and severity of gastroesophageal reflux disease. Am J Gastroenterol. 2001; 96 1711-1717
- 41 Avidan B, Sonnenberg A, Schnell T G. et al . Hiatal hernia size, Barrett’s length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol. 2002; 97 (8) 1930-1936
- 42 Stylopoulos N, Gazelle G S, Rattner D W. Paraesophageal hernias: operation or observation. Ann Surg. 2002; 236 492-501
- 43 Kleinmann E, Halbfass H J. Zur Problematik des „short esophagus” in der laparoskopischen Antirefluxchirurgie. Chirurg. 2001; 72 408-413
- 44 Streets C G, DeMeester S R, DeMeester T R. et al . Excellent quality of life after Nissen fundoplication depends on successful elimination of reflux symptoms and not the invasiveness of the surgical approach. Ann Thorac Surg. 2002; 74 (4) 1019-1024; discussion 1024-1025
- 45 Deschamps C, Allen M S, Trastek V F. et al . Early experience and learning curve associated with laparoscopic Nissen fundoplication. J Thorac Cardiovasc Surg. 1998; 115 281-284
- 46 Rantanen T K, Halme T V, Luostarinen M E. et al . The long term results of open antireflux surgery in a community-based health care center. Am J Gastroenterol. 1999; 94 1777-1781
- 47 Rydberg L, Ruth M, Abrahamsson H. et al . Tailoring antireflux surgery: A randomized clinical trial. World J Surg. 1999; 23 612-618
- 48 Csendes A, Burdiles P, Korn O. et al . Late results of a randomized clinical trial comparing total fundoplication versus calibration of the cardia with posterior gastropexy. Br J Surg. 2000; 87 (3) 289-297
- 49 Bais J E, Bartelsman J F, Bonjer H J. et al . Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group. Lancet. 2000; 355 170-174
- 50 Hagedorn C, Lonroth H, Rydberg L. et al . Long-term efficacy of total (Nissen-Rossetti) and posterior partial (Toupet) fundoplication. Results of a randomized clinical trial. J Gastrointest Surg. 2002; 31 (6) (4) 540-545
- 51 Hüttl T P, Hohle M, Meyer G. et al . Antireflux surgery in Germany. Results of a representative survey with analysis of 2,540 antireflux operations. Chirurg. 2002; 73 (5) 451-461
- 52 Vakil N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic fundoplication in a U.S. community. Am J Med. 2003; 1114 1-5
- 53 Tan L C, Samanta S, Hosking S W. Safe transition from open to laparascopic fundoplication by an established consultant - the importance of repeated audit. Ann R Coll Surg Engl. 2002; 84 84-88
- 54 Menon V S, Manson J M, Baxter J N. Laparascopic fundoplication: learning curve and patient satisfaction. Ann R Coll Surg Engl. 2003; 85 10-13
- 55 Fibbe C, Layer P, Keller J. et al . Esophageal motility in reflux disease before and after fundoplication: A prospective, randomized, clinical, and manometric study. Gastroenterology. 2001; 121 (1) 5-14
- 56 Avidan B, Sonnenberg A, Schnell T G. et al . There are no reliable symptoms for erosive oesophagitis and Barrett’s oesophagus: endoscopic diagnosis is still essential. Aliment Pharmacol Ther. 2002; 16 735-742
- 57 Khajanchee Y S, O’Rourke R W, Lockhart B. et al . Postoperative symptoms and failure after antireflux surgery. Arch Surg. 2002; 137 1008-1013
- 58 Blom D, Peters J H, DeMeester T R. et al . Physiologic mechanism and preoperative prediction of new-onset dysphagia after laparoscopic Nissen fundoplication. J Gastrointest Surg. 2002; 6: (1) 22-27; discussion 27-28
- 59 Booth M, Stratford J, Dehn T C. Preoperative esophageal body motility does not influence the outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease. Dis Esophagus. 2002; 15 (1) 57-60
- 60 Martinez S D, Malagon I B, Garewal H S. et al . Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment Phamacol Ther. 2003; 17 537-545
- 61 Van der Burgh A, Dees J, Hop W C. et al . Oesophageal cancer is an uncommon cause of death in patients with Barrett’s oesophagus. GUT. 1996; 39 5-8
- 62 Sampliner R E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1998; 93 (7) 1028-1032
- 63 MacDonald C E, Wicks A C, Playford R J. Final results from 10 year cohort of patients undergoing surveillance for Barrett’s oesophagus. Observational study. Br Med J. 2000; 321 1252-1255
- 64 Sontag S J. Preventing death of Barrett’s cancer: does frequent surveillance endoscopy do it?. Am J Med. 2001; 3 (111 Suppl 8A) 137S-141
- 65 Corley D A, Levin T R, Habel L A. et al . Surveillance and survival in Barrett’s adenocarcinoma; a population-based study. Gastroenterology. 2002; 122 633-640
- 66 Parrilla P, de Martinez Haro LF, Ortiz A. et al . Standard antireflux operations in patients who have Barrett’s esophagus. Current results. Chest Surg Clin N Am. 2002; 12 113-126
- 67 Carlson M A, Frantzides C T. Complications and results of primary minimally invasive antireflux procedures: a review of 10,735 reported cases. J Am Coll Surg. 2001; 193 (4) 428-439
- 68 Schäfer H, Collet P, Wolfgarten E. et al . Endoskopische Gastroplastik zur Behandlung der gastroösophagealen Refluxerkrankung - eine Pilotstudie. Visceralchirurgie. 2001; 36 362-366
- 69 Devière J, Pastorelli A, Louis H. et al . Endoscopic implantation of a biopolymer in the lower esophageal sphincter for gastroesophageal reflux: a pilot study. Gastrointest Endosc. 2002; 55 (3) 335-341
- 70 Triadafilopoulos G, DiBaise J K, Nostrant T T. et al . The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc. 2002; 55 (2) 149-156
- 71 Wolfsen H C, Richards W O. The Stretta procedure for the treatment of GERD: a registry of 558 patients. J Laparoendosc Adv Surg Tech. 2002; 12 395-402
- 72 Mahmood Z, McMahon B P, Arfin Q. et al . Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up. Gut. 2003; 52 (1) 34-39
- 73 Peters J H, Silverman D E, Stein A. Lower esophageal sphincter injection of a biocompatible polymer. Surg Endosc. 2003; 17 (4) 547-550
- 74 Heudebert G R, Marks R, Wilcox M. et al . Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis. Gastroenterology. 1997; 112 1078-1086
- 75 Myrvold H E, Lundell L, Miettinen P. et al and the Nordic GORD Study Group. . The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery. Gut. 2001; 49 (4) 488-494
- 76 O’Connor J B, Provenzale D, Brazer S. Economic considerations in the treatment of gastroesophageal reflux disease: a review. Am J Gastroenterol. 2000; 95 (12) 3356-3364
- 77 Sonnenberg A. Motion - laparoscopic Nissen fundoplication is more cost effective than oral PPI administration: arguments against the motion. Can J Gastroenterol. 2002; 16 627-631
- 78 Swanström L L. Motion - laparoscopic Nissen fundoplication is more cost effective than oral PPI administration: arguments for the motion. Can J Gastroenterol. 2002; 16 621-623
- 79 Hadorn D C, Baker D. Development of the AHCPR-sponsored heart failure guideline: methodologic and procedural issues. Jt Comm J Qual Improv. 1994; 20 539-547
- 80 Bollschweiler E. Nationale und klinikinterne Leitlinien: Definition und Problemlage. Lauterbach KW, Schrappe M Gesundheitsökonomie, Qualitätsmanagement und Evidence-based Medicine Stuttgart; Schattauer-Verlag 2001: 457-462
Prof. Dr. A. H. Hölscher
Klinik und Poliklinik für Visceral- und Gefäßchirurgie der Universität zu Köln
Joseph-Stelzmann-Str. 9
50931 Köln
Email: Arnulf.Hoelscher@medizin.uni-koeln.de